International Clinical Trial: A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (NCT07220083) titled 'A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)' on Oct. 22.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Boehringer Ingelheim

Condition: Focal Segmental Glomerulosclerosis

Intervention: Drug: BI 764198

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: December 5, 2025

Target Sample Size: 286

To know more, v...